TSX-V:QPT - TSX Venture Exchange - CA74836M1068 - Common Stock - Currency: CAD
TSX-V:QPT (7/29/2025, 7:00:00 PM)
0.04
0 (-11.11%)
The current stock price of QPT.CA is 0.04 CAD. In the past month the price increased by 14.29%. In the past year, price increased by 60%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 323.71M | ||
EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 259.27M | ||
EDT.CA | SPECTRAL MEDICAL INC | N/A | 236.98M | ||
TH.CA | THERATECHNOLOGIES INC | N/A | 200.01M | ||
ONC.CA | ONCOLYTICS BIOTECH INC | N/A | 127.90M | ||
WLLW.CA | WILLOW BIOSCIENCES INC | N/A | 122.74M | ||
HBP.CA | HELIX BIOPHARMA CORP | N/A | 78.61M | ||
MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 71.71M | ||
COV.CA | COVALON TECHNOLOGIES LTD | 19.62 | 69.92M | ||
MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 55.19M | ||
BLU.CA | BLUENERGIES LTD | N/A | 54.52M | ||
SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 52.45M |
Quest PharmaTech, Inc. is a biotechnology company, which develops and commercializes antibody based immunotherapeutic products for cancer. The company is headquartered in Edmonton, Alberta. The firm is developing products to improve the quality of life. The firm is also developing a proprietary MAb AR 9.6 targeting truncated MUC16 as theranostic agents for cancer. The firm has a 42.5% ownership interest in OncoQuest Inc. (OncoQuest), a Canadian biotechnology company developing combinatorial immunotherapy products for the treatment of cancer. OncoQuest’s technology platform included a panel of tumor antigen-specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. The company also has a 23% ownership interest in OncoVent Co., Ltd. (OncoVent), which is developing antibody-based immunotherapeutic products for cancer for the Greater China territory.
QUEST PHARMATECH INC
4342 97 Street
Edmonton ALBERTA T6E 6S4 CA
CEO: Ragupathy Madiyalakan,
Employees: 0
Phone: 17804481400
The current stock price of QPT.CA is 0.04 CAD. The price decreased by -11.11% in the last trading session.
The exchange symbol of QUEST PHARMATECH INC is QPT and it is listed on the TSX Venture Exchange exchange.
QPT.CA stock is listed on the TSX Venture Exchange exchange.
QUEST PHARMATECH INC (QPT.CA) has a market capitalization of 6.77M CAD. This makes QPT.CA a Nano Cap stock.
QUEST PHARMATECH INC (QPT.CA) currently has 0 employees.
QUEST PHARMATECH INC (QPT.CA) has a support level at 0.04 and a resistance level at 0.05. Check the full technical report for a detailed analysis of QPT.CA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
QPT.CA does not pay a dividend.
QUEST PHARMATECH INC (QPT.CA) will report earnings on 2025-09-22.
ChartMill assigns a technical rating of 7 / 10 to QPT.CA. When comparing the yearly performance of all stocks, QPT.CA is one of the better performing stocks in the market, outperforming 80.3% of all stocks.
ChartMill assigns a fundamental rating of 1 / 10 to QPT.CA. QPT.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -1.06% | ||
ROE | -1.11% | ||
Debt/Equity | 0.05 |